welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!
enrolling by invitation

Givinostat in Duchenne’s Muscular Dystrophy Long-term Safety and Tolerability Study

key information

study id #: NCT03373968

condition: Duchenne Muscular Dystrophy

status: enrolling by invitation


This is an open label, long-term safety, tolerability, and efficacy study of GIVINOSTAT in all DMD (Duchenne’s muscular dystrophy) patients who have been previously treated in one of the GIVINOSTAT studies.

intervention: Givinostat

mechanism of action: Histone deacetylase (HDAC) inhibitor to reduce inflammation and promote muscle health

results: https://clinicaltrials.gov/ct2/show/results/NCT03373968

last updated: November 30, 2020